Label: DERMA UNDER EYE- hyaluronic acid, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7 gel

  • NDC Code(s): 82160-443-01
  • Packager: Pella Pharmaceuticals Co. Ltd
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: unapproved drug other

DISCLAIMER: This drug has not been found by FDA to be safe and effective, and this labeling has not been approved by FDA. For further information about unapproved drugs, click here.

Drug Label Information

Updated November 29, 2021

If you are a consumer or patient please visit this version.

View All Sections
  • Forms and Presentation

    Gel: Tube of 15 g.

  • Active Ingredients

    Hyaluronic Acid

    Palmitoyl Tripeptide-1

    Palmitoyl Tetrapeptide-7

  • Inactive Ingredients

    Aqua, Glycerin, Cetearyl Ethylhexanoate, Benzyl Alcohol, Polysorbate 20, Sodium Hydroxide, Carbomer, Hydroxyethylcellulose, Potassium Sorbate, Steareth-20, N- Hydroxysuccinimide, Chrysin.

  • Purpose

    Under eye gel for dark circles

  • Properties

    Under eye gel reduces dark circles and fine lines around the eye, therefore moisturizes and brightens it.
    Paraben free.

  • Indications

    Gel for Dark circles under eye.

  • Precautions

    Keep out of reach of children

  • Warnings

    • For external use only
    • Avoid contact with eyes and mucous membranes.
  • Contraindications

    Hypersensitivity to any of the components.

  • Side effects

    There are no known side effects.

  • Dosage and administration

    After cleansing, apply the gel onto your finger and gently pat it around your eyes. Use it morning and evening on Dark Circles.

  • Storage conditions

    Store at a temperature below 30 °C.

  • Primary Package

    Primary Package

  • Secondary Package

    Secondary Package

  • INGREDIENTS AND APPEARANCE
    DERMA UNDER EYE 
    hyaluronic acid, palmitoyl tripeptide-1, palmitoyl tetrapeptide-7 gel
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:82160-443
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    PALMITOYL TRIPEPTIDE-1 (UNII: RV743D216M) (PALMITOYL TRIPEPTIDE-1 - UNII:RV743D216M) PALMITOYL TRIPEPTIDE-10.0003 mg  in 15 g
    HYALURONIC ACID (UNII: S270N0TRQY) (HYALURONIC ACID - UNII:S270N0TRQY) HYALURONIC ACID0.15 mg  in 15 g
    PALMITOYL TETRAPEPTIDE-7 (UNII: Q41S464P1R) (PALMITOYL TETRAPEPTIDE-7 - UNII:Q41S464P1R) PALMITOYL TETRAPEPTIDE-70.00015 mg  in 15 g
    Inactive Ingredients
    Ingredient NameStrength
    GLYCERIN (UNII: PDC6A3C0OX)  
    STEARETH-20 (UNII: L0Q8IK9E08)  
    N-HYDROXYSUCCINIMIDE (UNII: MJE3791M4T)  
    CHRYSIN (UNII: 3CN01F5ZJ5)  
    POTASSIUM SORBATE (UNII: 1VPU26JZZ4)  
    POLYSORBATE 20 (UNII: 7T1F30V5YH)  
    CARBOMER 940 (UNII: 4Q93RCW27E)  
    BENZYL ALCOHOL (UNII: LKG8494WBH)  
    HYDROXYETHYL CELLULOSE, UNSPECIFIED (UNII: T4V6TWG28D)  
    WATER (UNII: 059QF0KO0R)  
    CETEARYL ETHYLHEXANOATE (UNII: 9M64UO4C25)  
    SODIUM HYDROXIDE (UNII: 55X04QC32I)  
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:82160-443-011 in 1 CARTON12/24/2014
    115 g in 1 TUBE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    unapproved drug other12/24/2014
    Labeler - Pella Pharmaceuticals Co. Ltd (562370925)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!